Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Results ALCAR reduces PCa cell viability and induces apoptosis We tested the ability of ALCAR at different concentrations (50 M, 100 M 200 M, 500 M, 1 mM, 5 mM and 10 mM) to reduce cell growth in four PCa (PC-3, DU-145, LNCaP, 22Rv1) and BPH cell lines, by using crystal violet assay (data not shown)
Cannot redeclare control with same name "grid_6_qv_cta_typography_line_height"
Common side effects, including: Nausea Vomiting Diarrhoea Constipation Abdominal pain Headache Fatigue Dizziness Low blood sugar (hypoglycaemia) in patients with diabetes
PRESS RELEASE PrecisionLife and Ovation ink collaboration agreement to launch GLP-1 stratification LDT and consumer GLP-1 DNA test in 2026 Companies confirm that markers of weight loss and glycemic control are distinct in preliminary study, with multiple mechanisms identified that provide opportunities to guide indication extension OXFORD, UK and PORTLAND, ME 15 April 2026 Ovation.io, a leading human omics and clinical data company, and PrecisionLife, a precision medicine company transforming how complex chronic diseases are understood and managed, today announced that they have reached agreement to commercialize the outputs of PrecisionLifes analysis of Ovations high quality GLP-1 receptor agonist dataset
US$ 24.51
US$ 23.32
US$ 29.70
US$ 29.05
US$ 20.19
